Indivior Pharmaceuticals (INDV) Inventory (2021 - 2026)

Indivior Pharmaceuticals' Inventory history runs 6 years deep, the most recent figure standing at $152.0 million for Q1 2026.

• In Q1 2026, Inventory fell 6.75% year-over-year to $152.0 million; the TTM figure through Mar 2026 stood at $152.0 million (down 6.75% YoY), while the FY2025 annual figure was $153.0 million, down 8.38% from the prior year.
• Inventory was $152.0 million for Q1 2026 at Indivior Pharmaceuticals, down from $153.0 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $167.0 million in Q4 2024 to a low of $114.0 million in Q4 2022.
• Historically, Inventory has averaged $147.4 million across 5 years, with a median of $152.5 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Inventory surged 32.54% in 2024, then slipped 8.38% in 2025.
• A 5-year view of Inventory shows it stood at $114.0 million in 2022, then climbed by 10.53% to $126.0 million in 2023, then soared by 32.54% to $167.0 million in 2024, then retreated by 8.38% to $153.0 million in 2025, then decreased by 0.65% to $152.0 million in 2026.
• The last three Inventory figures came in at $152.0 million (Q1 2026), $153.0 million (Q4 2025), and $155.0 million (Q3 2025), per Business Quant data.